Amphastar Pharmaceuticals

Amphastar Pharmaceuticals, Inc., headquartered in Rancho Cucamonga, California, established in 1996, is a recognized specialty pharmaceutical company that uses state-of-the-art, cGMP compliant facilities to develop, manufacture, and market injectable and inhalation products. In addition to the Corporate Headquarters, Amphastar has five manufacturing facilities located in the United States, China and Europe along with a state-of-the-art New Drug Research Center. Amphastar and its subsidiaries each have their own distinct focus that they skillfully bring together to meet the varied needs of the pharmaceutical industry. We currently produce approximately 15 injectable products while we continue to develop a portfolio of generic and branded products that target large markets with high technical barriers to entry. Amphastar’s long-standing relationship with the major group purchasing organizations and drug wholesalers in the U.S. enables it to establish significant market share upon the introduction of its new products.
Rancho Cucamonga, US
1,460 (est)+8%
Amphastar Pharmaceuticals was founded in 1996 and is headquartered in Rancho Cucamonga, US

Amphastar Pharmaceuticals Locations

Rancho Cucamonga, US

Amphastar Pharmaceuticals Metrics

Amphastar Pharmaceuticals Summary

Market capitalization

$729 M

Closing share price

Amphastar Pharmaceuticals's current market capitalization is $729 M.

Amphastar Pharmaceuticals Financials

Amphastar Pharmaceuticals's revenue is $252 M in FY, 2015 which is 19.51% increase from the previous period.
FY, 2013FY, 2014FY, 2015


$210 M$252 M

Gross profit

$51.3 M$77.3 M

Operating income

$-18 M$-6.9 M

Operating expense total

$69.2 M$84.2 M

Interest expense

$958 K$609 K$987 K

Income tax expense

$5.37 M$-7.45 M$-7.58 M

Net Income

$-10.7 M$-2.79 M

Operating cash flow

$14.2 M$-1.75 M

    Amphastar Pharmaceuticals Market Value History

    Amphastar Pharmaceuticals News

    Amphastar Pharmaceuticals Company Life

    You may also be interested in